1. Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7
- Author
-
Tobias Weinert, Steffen Bruenle, Tim Tetaz, Przemyslaw Nogly, Andreas Kuglstatter, Alain Gast, Jean-Marie Vonach, Antonia Furrer, Joerg Standfuss, Chia-Ying Huang, Jonas Muehle, Daniel Mattle, Kathrin Jaeger, Noemi Haenggi, Takuya Miyazaki, Roger J. P. Dawson, Joerg Benz, Martin Weber, Wolfgang Guba, and Markus G. Rudolph
- Subjects
Receptors, CCR7 ,crystal structure ,Receptors, CCR2 ,Recombinant Fusion Proteins ,Allosteric regulation ,Neuraminidase ,C-C chemokine receptor type 7 ,chemokine receptors ,membrane proteins ,Biology ,Molecular Dynamics Simulation ,Crystallography, X-Ray ,Ligands ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,Chemokine receptor ,0302 clinical medicine ,Allosteric Regulation ,G protein-coupled receptors ,structure-based drug screening ,Humans ,cancer ,Receptor ,030304 developmental biology ,G protein-coupled receptor ,0303 health sciences ,Binding Sites ,allosteric modulation ,lymph node metastasis ,Ligand ,3. Good health ,Cell biology ,Protein Structure, Tertiary ,Transmembrane domain ,CC chemokine receptors ,030217 neurology & neurosurgery ,Protein Binding ,CCR7 - Abstract
Summary The CC chemokine receptor 7 (CCR7) balances immunity and tolerance by homeostatic trafficking of immune cells. In cancer, CCR7-mediated trafficking leads to lymph node metastasis, suggesting the receptor as a promising therapeutic target. Here, we present the crystal structure of human CCR7 fused to the protein Sialidase NanA by using data up to 2.1 Å resolution. The structure shows the ligand Cmp2105 bound to an intracellular allosteric binding pocket. A sulfonamide group, characteristic for various chemokine receptor ligands, binds to a patch of conserved residues in the Gi protein binding region between transmembrane helix 7 and helix 8. We demonstrate how structural data can be used in combination with a compound repository and automated thermal stability screening to identify and modulate allosteric chemokine receptor antagonists. We detect both novel (CS-1 and CS-2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin) CCR7 modulators with implications for multi-target strategies against cancer., Graphical Abstract, Highlights • Crystal structure of the CC chemokine receptor 7 • Cmp2105 is an intracellular allosteric CCR7 receptor antagonist • The TM7-H8 turn is a pharmacological hotspot for targeting chemokine receptors • Navarixin is a multi-target antagonist with implications for cancer therapy, An engineered version of human CCR7, fused to Sialidase NanA, is used to overcome a protein crystallization challenge, leading to a high-resolution structure of CCR7 bound to an intracellular domain antagonist and a computational screen that identifies a series of CCR7 modulators, including Navarixin.
- Published
- 2019